AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

SYK · NYSE · Medical - Devices

Stryker (SYK)

Pairs orthopaedic implants with Mako robotics, surgical equipment and vascular devices.

$275.27

After hours+0.22 (+0.08%)

At close$275.05(+0.31%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	4,909	5,815	5,243	5,422	5,494	6,436	5,866	6,022	6,057	7,171	6,020	6,589
Cost of revenue	1,889	2,261	2,049	2,098	2,101	2,447	2,186	2,272	2,205	2,494	2,210	2,091
Gross profit	3,020	3,554	3,194	3,324	3,393	3,989	3,680	3,750	3,852	4,677	3,810	4,498
	2,029	2,129	2,191	2,166	2,185	2,326	2,501	2,389	2,717	2,716	2,874	2,839
Research & development	335	328	356	352	364	342	393	396	410	401	413	434
Selling, general & administrative	1,694	1,801	1,835	1,814	1,821	1,984	2,108	1,993	2,045	2,227	2,281	2,229
Other expenses	0	0	0	0	0	0	0	0	262	88	180	176
Operating income	991	1,425	1,003	1,158	1,208	1,663	1,179	1,361	1,135	1,961	936	1,659
	−122	−199	−80	−160	−165	−1,135	−415	−345	−106	−256	−86	−95
Interest income	15	35	36	26	30	47	38	24	28	0	0	0
Interest expense	0	0	0	0	0	0	0	159	157	381	148	0
Other non-operating income	122	199	80	160	165	1,135	415	186	106	247	−62	95
Income before tax	869	1,226	923	998	1,043	528	764	1,016	1,029	1,705	850	1,564
Income tax expense	177	83	135	173	209	−18	110	132	170	856	105	288
Net income from continuing operations	692	1,143	788	825	834	546	654	884	859	849	745	1,276
Net income	692	1,143	788	825	834	546	654	884	859	849	745	1,276
EPS, basic	$1.82	$3.01	$2.07	$2.17	$2.19	$1.43	$1.71	$2.32	$2.25	$2.21	$1.95	$3.32
EPS, diluted	$1.80	$2.98	$2.05	$2.14	$2.16	$1.41	$1.69	$2.29	$2.22	$2.20	$1.93	$3.30
Weighted average shares, basic	380	380	380	381	381	381	382	382	382	383	383	384
Weighted average shares, diluted	384	384	385	385	386	386	386	386	387	387	387	386
EBITDA	1,131	1,476	1,183	1,256	1,311	792	1,036	1,471	1,363	2,030	1,298	1,564
Depreciation & amortization	262	250	260	258	268	264	272	296	334	316	300	0
EBIT	869	1,226	923	998	1,043	528	764	1,175	1,029	1,714	998	1,564